TG Forum Logo TG Forum Logo

Vupanorsen (Pfizer-led clinical development programme discontinued in January 2022)

You are here: Home > Archives for ANGPTL3 inhibitors > Vupanorsen (Pfizer-led clinical development programme discontinued in January 2022)

Ongoing Trials

Completed Trials

Educational partners and supporters

Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc. Arrowhead Pharmaceuticals
Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc. Ionis Logo
Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc. Kowa Logo